Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Said to Have Decided Against Bid for Rest of Chugai
Bloomberg
Monday, August 25, 2014 - 9:10am
tags:
Roche, Chugai, M&A, InterMune
The real 'exclusive' at Merck: R&D is back in the saddle, baby
Fierce Biotech
Monday, August 25, 2014 - 8:48am
tags:
Merck, R&D, melanoma, Pembrolizumab
Roche CEO On Intermune Deal: 'This Is A Growth Story'
Forbes
Monday, August 25, 2014 - 8:37am
tags:
Pharma CEOs, InterMune, Roche, M&A, Severin Schwan
Allergan reviewing special meeting requests as Valeant ratchets up $53B hostile takeover bid
Yahoo/AP
Monday, August 25, 2014 - 8:33am
tags:
M&A, Valeant Pharmaceuticals, Allergan
Valeant Says Allergan Investors Demand Meeting on Deal
Bloomberg
Monday, August 25, 2014 - 8:32am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Regado permanantly halts enrollment in lead drug trial
Yahoo/AP
Monday, August 25, 2014 - 8:27am
tags:
Regado Biosciences, clinical trials, Revolixys, bloodthinners
3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology
Yahoo/Benzinga
Monday, August 25, 2014 - 8:25am
tags:
genetic engineering, plantibodies, antibodies, iBio, PlantForm, Protalix BioTherapeutics
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Yahoo/Reuters
Monday, August 25, 2014 - 8:20am
tags:
Roche, InterMune, M&A
Advaxis, Merck to test immune therapies against prostate cancer
Yahoo/Reuters
Monday, August 25, 2014 - 8:19am
tags:
Advaxis, Merck, prostate cancer, immuno-oncology
Roche's InterMune Acquisition Underscores How It And Pfizer Are On Different M&A Paths
Forbes
Monday, August 25, 2014 - 8:14am
tags:
Roche, InterMune, Pfizer, M&A
Mylan Launches First Generic Klor-Con Extended-Release Tablets
Sys-Con Media
Sunday, August 24, 2014 - 8:51am
tags:
Mylan, generics
Britain braced for a bargain 'Viagra' boom: Thousands more to get impotence pills on NHS as price plunges 93% Read more: http:
Daily Mail, UK
Sunday, August 24, 2014 - 8:48am
tags:
UK, Viagra, generics
3 Reasons Bristol-Myers Squibb's Stock Could Rise
Motley Fool
Saturday, August 23, 2014 - 10:17am
tags:
Bristol-Myers Squibb
Data on Celgene's Revlimid Published in Oncology Journal
Yahoo/Zacks
Saturday, August 23, 2014 - 9:52am
tags:
Celgene, Revlimid, diffuse large B-cell lymphoma, lymphoma
Glaxo, Pfizer’s ViiV Wins Approval for HIV Combo Drug
Bloomberg
Saturday, August 23, 2014 - 9:50am
tags:
Glaxo, Pfizer, ViiV, HIV
Illumina: Making Markets By Unlocking The Genome
Investor's Business Daily
Saturday, August 23, 2014 - 9:48am
tags:
Illumina
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod
Yahoo/Zacks
Saturday, August 23, 2014 - 9:45am
tags:
Bristol-Myers Squibb, Eliquis, deep vein thrombosis, pulmonary embolism
Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf
The Street
Saturday, August 23, 2014 - 9:43am
tags:
JNJ, Abbott Laboratories
Eli Lilly Uncovers Positive Data from Ixekizumab Studies
Yahoo/Zacks
Saturday, August 23, 2014 - 9:41am
tags:
Eli Lilly, ixekizumab, chronic plaque psoriasis
AstraZeneca Updates on PLATO Study Investigation on Brilinta
Yahoo/Zacks
Saturday, August 23, 2014 - 9:39am
tags:
AstraZeneca, Brilinta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.